Mateon Therapeutics Inc. buy melinda
Start price
27.01.17
/
50%
€0.37
Target price
15.02.17
€0.50
Performance (%)
34.58%
End price
15.02.17
€0.50
Summary
This prediction ended on 15.02.17 with a price of €0.50. With a performance of 34.58% the BUY prediction by melinda was a big success. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Mateon Therapeutics Inc. | - | - | - | - |
| iShares Core DAX® | 1.085% | -0.846% | 12.464% | 58.472% |
| iShares Nasdaq 100 | -1.665% | -3.306% | 1.502% | 84.473% |
| iShares Nikkei 225® | 3.863% | 6.308% | 22.272% | 56.185% |
| iShares S&P 500 | 0.111% | -1.337% | 1.101% | 58.320% |
Comments by melinda for this prediction
In the thread Mateon Therapeutics Inc. diskutieren
Eierstockkrebs
a +
(Zielkurs erreicht)


